Global Transplant Diagnostics Market Report (2018-2023) – The Molecular Assay Technology Segment is Expected to Account for the Largest Share of the Market

Dublin, July 12, 2018 (GLOBE NEWSWIRE) -- The "Transplant Diagnostics Market by Technology, Product, Application, Type, End User - Global Forecast to 2023" report has been added to's offering.

The global transplant diagnostics market is projected to reach USD 4.91 billion by 2023 from USD 3.44 billion in 2018, at a CAGR of 7.4%.

Increasing number of transplantation procedures, technological advancements in the field of transplant diagnostics, increasing public-private funding for target research activities, and growing burden of infectious diseases are some of the factors responsible for the growth of this market. However, the high procedural cost for next-generation sequencing (NGS) and PCR-based diagnostics assays and limited availability of reimbursements for target procedures are expected to limit the optimal adoption of transplant diagnostics during the forecast period.

This report broadly segments the market into technology, product, transplant type, application, end user, and region. On the basis of technology, the market is segmented into molecular and non-molecular assay technologies. In 2018, the molecular assay technology segment is expected to account for the largest share of the market. This can be attributed to the expansion in the distribution network of key transplant diagnostic manufacturers across emerging countries (through strategic acquisitions, collaborations, and strengthening manufacturing capabilities) and increasing private funding to develop innovative transplant diagnostic products.

Based on product & service, the market is categorized into reagents & consumables, instruments, and software & services. The reagents & consumables segment accounted for the largest share of the market in 2018. Growing adoption of transplant diagnostic techniques in related research studies and rising number of organ transplantation procedures across major markets are the key factors supporting the growth of the transplant diagnostics market for reagents and consumables.

On the basis of transplant type, the market is categorized into solid organ, stem cell, and soft tissue transplantation. The solid organ transplantation segment accounted for the largest share of the market in 2018. Increasing number of solid organ transplantation procedures, supportive government regulations to augment organ donations across major healthcare markets, and rising number of chronic diseases/disorders that leads to transplantation are the key factors supporting the growth of the market for solid organ transplantation.

Based on application, the market is categorized into diagnostic and research applications. The diagnostic applications segment accounted for the largest share of the market in 2018. The rising incidence of chronic diseases (that often lead to transplantation in critical and terminal patients) and greater risk of genetic disorders and pathogenic infections after transplantation (due to weaker immunity in geriatric recipients and discovery of novel biomarkers to identify genetic disorders) are the key factors supporting the growth of the transplant diagnostics market for diagnostic applications.

Based on end user, the market is segmented into three categories, namely, independent reference laboratories, hospitals and transplant centers, and research laboratories & academic institutes. In 2018, the independent reference laboratories segment is expected to account for the largest share of the market due to increasing global demand for infectious disease diagnosis and tissue typing during donor-recipient profiling/cross-matching, growing number of organ transplantation procedures, and growing inauguration & accreditation of diagnostic laboratories across emerging as well as developed countries.

This report covers the market across four major regions, namely, North America, Europe, Asia Pacific, and the RoW. North America is expected to command the largest share of the market in 2018. The large share of North America in the global transplant diagnostics market is attributed to the high budgetary allocation for healthcare expenditure, large volume of organ transplantation procedures performed in the region, and technological advancements in the field of transplant diagnostics.

Key Topics Covered

1 Introduction
1.1 Objectives of the Study
1.2 Market Definition
1.3 Market Scope
1.3.1 Markets Covered
1.3.2 Geographic Scope
1.3.3 Years Considered for the Study
1.4 Currency Used for the Study
1.5 Major Market Stakeholders

2 Research Methodology
2.1 Research Data
2.1.1 Secondary Data
2.1.2 Primary Data
2.2 Market Size Estimation
2.2.1 Product-Based Market Estimation
2.2.2 Procedure Based Market Estimation
2.2.3 Primary Research Validation
2.3 Data Triangulation
2.4 Research Assumptions
2.5 Research Limitations

3 Executive Summary

4 Premium Insights
4.1 Transplant Diagnostics Market Overview
4.2 Market, By Technology
4.3 Regional Analysis: Market, By Application
4.4 Asia Pacific: Market, By End User, 2018
4.5 Regional Analysis: Market, By Product & Service
4.6 Regional Analysis: Market, By Transplant Type
4.7 Transplant Diagnostics Market, By Country

5 Market Overview
5.1 Introduction
5.2 Market Dynamics
5.2.1 Key Market Drivers Increasing Number of Transplant Procedures Technological Advancements in the Field of Transplant Diagnostics Increasing Public-Private Funding for Target Research Activities Growing Burden of Infectious Diseases
5.2.2 Key Market Restraints High Procedural Cost of NGS and PCR-Based Diagnostic Assays Limited Reimbursements for Target Procedures
5.2.3 Key Market Opportunities Rising Adoption of Cross-Matching and Chimerism Testing During Pre- & Post-Transplantation Increasing Public Awareness About Organ Donation and Transplantation Across Emerging Countries
5.2.4 Key Market Challenges Significant Gap Between the Number of Organ Donors and Organs Required Annually Procedural and Technical Limitations Associated With Donor-Recipient Screening

6 Transplant Diagnostics Market, By Product and Services
6.1 Introduction
6.2 Reagents and Consumables
6.3 Instruments
6.4 Software and Services

7 Transplant Diagnostics Market, By Technology
7.1 Introduction
7.2 Molecular Assays
7.2.1 PCR-Based Molecular Assays Real-Time PCR Sequence-Specific Primer-PCR Sequence-Specific Oligonucleotide-PCR Other PCR-Based Molecular Assays
7.2.2 Sequencing-Based Molecular Assays Sanger Sequencing Next-Generation Sequencing Other Sequencing Molecular Assays
7.3 Non-Molecular Assays

8 Transplant Diagnostics Market, By Transplant Type
8.1 Introduction
8.2 Solid Organ Transplantation
8.2.1 Kidney Transplantation
8.2.2 Liver Transplantation
8.2.3 Heart Transplantation
8.2.4 Lung Transplantation
8.2.5 Pancreas Transplantation
8.2.6 Other Organ Transplantations
8.3 Stem Cell Transplantation
8.4 Soft Tissue Transplantation

9 Transplant Diagnostics Market, By Application
9.1 Introduction
9.2 Diagnostic Applications
9.2.1 Pre-Transplantation Diagnostics Infectious Disease Testing Histocompatibility Testing Blood Profiling
9.2.2 Post-Transplantation Diagnostics
9.3 Research Applications

10 Transplant Diagnostics Market, By End User
10.1 Introduction
10.2 Independent Reference Laboratories
10.3 Hospitals & Transplant Centers
10.4 Research Laboratories & Academic Institutes

11 Transplant Diagnostics Market, By Region
11.1 Introduction
11.2 North America
11.2.1 US
11.2.2 Canada
11.3 Europe
11.3.1 Germany
11.3.2 UK
11.3.3 France
11.3.4 Rest of Europe
11.4 Asia Pacific
11.4.1 Japan
11.4.2 China
11.4.3 India
11.4.4 Rest of Asia Pacific
11.5 Rest of the World

12 Competitive Landscape
12.1 Overview
12.2 Market Share Analysis
12.3 Competitive Scenario
12.3.1 Key Product Launches and Enhancements (2014 to 2018)
12.3.2 Key Agreements, Partnerships, and Collaborations (2014 to 2018)
12.3.3 Major Acquisitions (2014 to 2018)
12.3.4 Key Expansions (2014 to 2018)

13 Company Profiles
13.1 Introduction
13.2 Becton, Dickinson and Company
13.3 Biofortuna
13.4 Biomrieux SA
13.5 Bio-Rad Laboratories
13.6 Caredx
13.7 F. Hoffman-La Roche Limited
13.8 Gendx
13.9 Hologic
13.10 Illumina
13.11 Immucor
13.12 Luminex
13.13 Merck KGaA
13.14 Omixon
13.15 Qiagen
13.16 Thermo Fisher Scientific

For more information about this report visit


         Laura Wood, Senior Manager
         For E.S.T Office Hours Call 1-917-300-0470
         For U.S./CAN Toll Free Call 1-800-526-8630
         For GMT Office Hours Call +353-1-416-8900
         Related Topics: Diagnostics